-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A1pprJKSjqitKwcXSDxz51QW61qAWYRvknNue7sGjZborVWv3cN3aMVpkshlIZty fqzFlzklgqdOToTNbeXmrw== 0001441848-10-000015.txt : 20100423 0001441848-10-000015.hdr.sgml : 20100423 20100423114103 ACCESSION NUMBER: 0001441848-10-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100421 FILED AS OF DATE: 20100423 DATE AS OF CHANGE: 20100423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROSS HERB CENTRAL INDEX KEY: 0001230721 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34154 FILM NUMBER: 10766353 MAIL ADDRESS: STREET 1: 3061 ZANKER RD CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FACET BIOTECH CORP CENTRAL INDEX KEY: 0001441848 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263070657 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1500 SEAPORT BLVD. CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-454-1000 MAIL ADDRESS: STREET 1: 1500 SEAPORT BLVD. CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Biotech Spinco, Inc. DATE OF NAME CHANGE: 20080804 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2010-04-21 0 0001441848 FACET BIOTECH CORP FACT 0001230721 CROSS HERB C/O FACET BIOTECH CORPORATION 1500 SEAPORT BLVD. REDWOOD CITY CA 94063 0 1 0 0 VP of Finance Common Stock 2010-04-21 4 D 0 11602 27 D 0 D Stock Option (Right to Buy) 6.17 2010-04-21 4 D 0 14000 27 D 2016-12-23 Common Stock 14000 0 D Stock Option (Right to Buy) 9.55 2010-04-21 4 D 0 6866 27 D 2016-04-02 Common Stock 6866 0 D Stock Option (Right to Buy) 9.95 2010-04-21 4 D 0 7000 27 D 2016-08-06 Common Stock 7000 0 D These shares were canceled and exchanged for a cash payment of $ 313,254.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. This stock option was canceled and exchanged for a cash payment of $291,620.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option. This stock option was canceled and exchanged for a cash payment of $119,811.70 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option. 4. This stock option was canceled and exchanged for a cash payment of $119,350.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option. /s/ Herb Cross 2010-04-21 -----END PRIVACY-ENHANCED MESSAGE-----